223 related articles for article (PubMed ID: 8806699)
21. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.
Klugbauer S; Rabes HM
Oncogene; 1999 Jul; 18(30):4388-93. PubMed ID: 10439047
[TBL] [Abstract][Full Text] [Related]
22. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus.
Pisarchik AV; Ermak G; Fomicheva V; Kartel NA; Figge J
Thyroid; 1998 Feb; 8(2):133-9. PubMed ID: 9510121
[TBL] [Abstract][Full Text] [Related]
23. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.
Smida J; Salassidis K; Hieber L; Zitzelsberger H; Kellerer AM; Demidchik EP; Negele T; Spelsberg F; Lengfelder E; Werner M; Bauchinger M
Int J Cancer; 1999 Jan; 80(1):32-8. PubMed ID: 9935226
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas.
Unger K; Zitzelsberger H; Salvatore G; Santoro M; Bogdanova T; Braselmann H; Kastner P; Zurnadzhy L; Tronko N; Hutzler P; Thomas G
J Clin Endocrinol Metab; 2004 Sep; 89(9):4272-9. PubMed ID: 15356021
[TBL] [Abstract][Full Text] [Related]
25. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.
Salassidis K; Bruch J; Zitzelsberger H; Lengfelder E; Kellerer AM; Bauchinger M
Cancer Res; 2000 Jun; 60(11):2786-9. PubMed ID: 10850414
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
[TBL] [Abstract][Full Text] [Related]
27. Gene rearrangements in radiation-induced thyroid carcinogenesis.
Rabes HM
Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
[TBL] [Abstract][Full Text] [Related]
28. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas.
Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY
J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation.
Bounacer A; Wicker R; Schlumberger M; Sarasin A; Suárez HG
Biochimie; 1997 Oct; 79(9-10):619-23. PubMed ID: 9466701
[TBL] [Abstract][Full Text] [Related]
30. The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2.
Minoletti F; Butti MG; Coronelli S; Miozzo M; Sozzi G; Pilotti S; Tunnacliffe A; Pierotti MA; Bongarzone I
Genes Chromosomes Cancer; 1994 Sep; 11(1):51-7. PubMed ID: 7529046
[TBL] [Abstract][Full Text] [Related]
31. RET oncogene puzzle in Chernobyl thyroid tumours.
Bonn D
Lancet; 1996 Apr; 347(9009):1176. PubMed ID: 8609764
[No Abstract] [Full Text] [Related]
32. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
[TBL] [Abstract][Full Text] [Related]
33. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.
Beimfohr C; Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Int J Cancer; 1999 Mar; 80(6):842-7. PubMed ID: 10074915
[TBL] [Abstract][Full Text] [Related]
34. Different significance of ret/PTC(1) and ret/PTC(3) rearrangements in thyroid carcinogenesis: lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation.
Cetta F; Gori M; Montalto G; Zuckermann M; Toti P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1429. PubMed ID: 11238550
[No Abstract] [Full Text] [Related]
35. ret rearrangements in Japanese pediatric and adult papillary thyroid cancers.
Motomura T; Nikiforov YE; Namba H; Ashizawa K; Nagataki S; Yamashita S; Fagin JA
Thyroid; 1998 Jun; 8(6):485-9. PubMed ID: 9669285
[TBL] [Abstract][Full Text] [Related]
36. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
Mizuno T; Iwamoto KS; Kyoizumi S; Nagamura H; Shinohara T; Koyama K; Seyama T; Hamatani K
Oncogene; 2000 Jan; 19(3):438-43. PubMed ID: 10656692
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic activation of the ret protooncogene in thyroid cancer.
Takahashi M
Crit Rev Oncog; 1995; 6(1):35-46. PubMed ID: 8573606
[TBL] [Abstract][Full Text] [Related]
38. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
39. Challenging dogma in thyroid cancer molecular genetics--role of RET/PTC and BRAF in tumor initiation.
Fagin JA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4264-6. PubMed ID: 15356019
[No Abstract] [Full Text] [Related]
40. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.
Chua EL; Wu WM; Tran KT; McCarthy SW; Lauer CS; Dubourdieu D; Packham N; O'Brien CJ; Turtle JR; Dong Q
J Clin Endocrinol Metab; 2000 Aug; 85(8):2733-9. PubMed ID: 10946873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]